| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology |
Departments of 1 Cell Biology and Physiology and 2 Pharmacology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
Requests for reprints: Donald B. DeFranco, Department of Pharmacology, University of Pittsburgh School of Medicine, 200 Lothrop Street, Pittsburgh, PA 15261. Phone: 412-624-4259; Fax: 412-648-1945; E-mail: dod1{at}pitt.edu.
Prostate gland development and growth requires both androgen action and epithelial-stromal communications. In fact, androgen signaling through the androgen receptor (AR) may be important in both stromal and epithelial cells of the prostate. Because interaction of AR with the coactivator, Hic-5/ARA55, results in enhanced androgen-induced transcription, we analyzed Hic-5/ARA55 expression in prostate tissue sections from normal human donors and prostate cancer patients. In each sample, Hic-5/ARA55 expression was confined to the stromal compartment of the prostate. Furthermore, a prostate stromal cell line, WPMY-1 cells, expresses Hic-5/ARA55, which is localized both at focal adhesion complexes and within the soluble cytoplasmic compartment. The ability of Hic-5/ARA55 to shuttle between the nuclear and cytoplasmic compartments was revealed on inhibition of nuclear export with leptomycin B. Small interfering RNA ablation experiments established endogenous Hic-5/ARA55 as a coactivator for both viral and endogenous cellular AR-regulated genes. Finally, the mechanism of Hic-5/ARA55 coactivator activity in WPMY-1 cells was revealed by chromatin immunoprecipitation analysis that showed its androgen-dependent recruitment to the promoter of the stromal androgen-responsive keratinocyte growth factor gene. These data provide the first demonstration of a stromal-specific AR coactivator that has an effect on an androgen-regulated growth factor that is essential for stromal/epithelial cell communication in the prostate. (Cancer Res 2006; 66(14): 7326-33)
This article has been cited by other articles:
![]() |
L. Aghajanova, M. C. Velarde, and L. C. Giudice The Progesterone Receptor Coactivator Hic-5 Is Involved in the Pathophysiology of Endometriosis Endocrinology, August 1, 2009; 150(8): 3863 - 3870. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Niu, S. Altuwaijri, K.-P. Lai, C.-T. Wu, W. A. Ricke, E. M. Messing, J. Yao, S. Yeh, and C. Chang Androgen receptor is a tumor suppressor and proliferator in prostate cancer PNAS, August 26, 2008; 105(34): 12182 - 12187. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. V. Heemers and D. J. Tindall Androgen Receptor (AR) Coregulators: A Diversity of Functions Converging on and Regulating the AR Transcriptional Complex Endocr. Rev., December 1, 2007; 28(7): 778 - 808. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. N. Sahu, S. Nunez, G. Bai, and A. Gupta Interaction of Pyk2 and PTP-PEST with leupaxin in prostate cancer cells Am J Physiol Cell Physiol, June 1, 2007; 292(6): C2288 - C2296. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |